Cryoprecipitate, containing Factor VIII, Factor XIII, von Willebrand Factor, fibrinogen, and fibronectin, is primarily used to treat acquired hypofibrinogenemia in cardiac surgery. The gene discussed is VWF; the disease is Hypofibrinogenemia.